1050 related articles for article (PubMed ID: 8857671)
21. Ferritin light chain down-modulation generates depigmentation in human metastatic melanoma cells by influencing tyrosinase maturation.
Maresca V; Flori E; Cardinali G; Briganti S; Lombardi D; Mileo AM; Paggi MG; Picardo M
J Cell Physiol; 2006 Mar; 206(3):843-8. PubMed ID: 16252260
[TBL] [Abstract][Full Text] [Related]
22. Regulation of tyrosinase gene expression by cAMP in B16 melanoma cells involves two CATGTG motifs surrounding the TATA box: implication of the microphthalmia gene product.
Bertolotto C; Bille K; Ortonne JP; Ballotti R
J Cell Biol; 1996 Aug; 134(3):747-55. PubMed ID: 8707852
[TBL] [Abstract][Full Text] [Related]
23. Coordinated mRNA and protein expression of human LAMP-1 in induction of melanogenesis after UV-B exposure and co-transfection of human tyrosinase and TRP-1 cDNAs.
Jimbow K; Luo D; Chen H; Hara H; Lee MH
Pigment Cell Res; 1994 Oct; 7(5):311-9. PubMed ID: 7886004
[TBL] [Abstract][Full Text] [Related]
24. Reduction of DNA synthesis, pigment synthesis, pigmentation gene mRNA and resistance to UVB in human melanoma cells treated with analogues of a histamine (H2) agonist.
Fechner GA; Michel J; Sturm RA; Jacobs JJ; Parsons PG
Biochem Pharmacol; 1994 Jul; 48(1):121-30. PubMed ID: 8043013
[TBL] [Abstract][Full Text] [Related]
25. Immunophenotyping of melanomas for tyrosinase: implications for vaccine development.
Chen YT; Stockert E; Tsang S; Coplan KA; Old LJ
Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8125-9. PubMed ID: 7667256
[TBL] [Abstract][Full Text] [Related]
26. The POU domain transcription factor Brn-2: elevated expression in malignant melanoma and regulation of melanocyte-specific gene expression.
Eisen T; Easty DJ; Bennett DC; Goding CR
Oncogene; 1995 Nov; 11(10):2157-64. PubMed ID: 7478537
[TBL] [Abstract][Full Text] [Related]
27. Pigment content of cultured human melanocytes does not correlate with tyrosinase message level.
Naeyaert JM; Eller M; Gordon PR; Park HY; Gilchrest BA
Br J Dermatol; 1991 Oct; 125(4):297-303. PubMed ID: 1720016
[TBL] [Abstract][Full Text] [Related]
28. Correlation between the number of melanosomes, tyrosinase mRNA levels, and tyrosinase activity in cultured murine melanoma cells in response to various melanogenesis regulatory agents.
Ando H; Itoh A; Mishima Y; Ichihashi M
J Cell Physiol; 1995 Jun; 163(3):608-14. PubMed ID: 7775602
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of growth and induction of differentiation of metastatic melanoma cells in vitro by genistein: chemosensitivity is regulated by cellular p53.
Rauth S; Kichina J; Green A
Br J Cancer; 1997; 75(11):1559-66. PubMed ID: 9184169
[TBL] [Abstract][Full Text] [Related]
30. Characterization of density-dependent regulation of the tyrosinase gene promoter: role of protein kinase C.
Mahalingam H; Watanabe A; Tachibana M; Niles RM
Exp Cell Res; 1997 Nov; 237(1):83-92. PubMed ID: 9417870
[TBL] [Abstract][Full Text] [Related]
31. Short and highly efficient synthetic promoters for melanoma-specific gene expression.
Martinelli R; De Simone V
FEBS Lett; 2005 Jan; 579(1):153-6. PubMed ID: 15620705
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory effect of Cinnamomum osmophloeum Kanehira ethanol extracts on melanin synthesis via repression of tyrosinase expression.
Lee SC; Chen CH; Yu CW; Chen HL; Huang WT; Chang YS; Hung SH; Lee TL
J Biosci Bioeng; 2016 Sep; 122(3):263-9. PubMed ID: 27084445
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of MITF and tyrosinase by paeonol-stimulated JNK/SAPK to reduction of phosphorylated CREB.
Bu J; Ma PC; Chen ZQ; Zhou WQ; Fu YJ; Li LJ; Li CR
Am J Chin Med; 2008; 36(2):245-63. PubMed ID: 18457359
[TBL] [Abstract][Full Text] [Related]
34. Selective induction of apoptosis in melanoma cells by tyrosinase promoter-controlled CD95 ligand overexpression.
Fecker LF; Geilen CC; Hossini AM; Schwarz C; Fechner H; Bartlett DL; Orfanos CE; Eberle J
J Invest Dermatol; 2005 Jan; 124(1):221-8. PubMed ID: 15654977
[TBL] [Abstract][Full Text] [Related]
35. MITF-M plays an essential role in transcriptional activation and signal transduction in Xiphophorus melanoma.
Delfgaauw J; Duschl J; Wellbrock C; Froschauer C; Schartl M; Altschmied J
Gene; 2003 Nov; 320():117-26. PubMed ID: 14597395
[TBL] [Abstract][Full Text] [Related]
36. Modulation of antioxidant enzymes p21WAF1 and p53 expression during proliferation and differentiation of human melanoma cell lines.
Bravard A; Petridis F; Luccioni C
Free Radic Biol Med; 1999 Apr; 26(7-8):1027-33. PubMed ID: 10232848
[TBL] [Abstract][Full Text] [Related]
37. Expression analysis of a tyrosinase promoter sequence in zebrafish.
Camp E; Badhwar P; Mann GJ; Lardelli M
Pigment Cell Res; 2003 Apr; 16(2):117-26. PubMed ID: 12622788
[TBL] [Abstract][Full Text] [Related]
38. Regulation of tyrosinase mRNA levels in mouse melanoma cell clones by melanocyte-stimulating hormone and cyclic AMP.
Hoganson GE; Ledwitz-Rigby F; Davidson RL; Fuller BB
Somat Cell Mol Genet; 1989 May; 15(3):255-63. PubMed ID: 2543086
[TBL] [Abstract][Full Text] [Related]
39. Repression of glucocorticoid receptor transactivation and DNA binding of a glucocorticoid response element within the serum/glucocorticoid-inducible protein kinase (sgk) gene promoter by the p53 tumor suppressor protein.
Maiyar AC; Phu PT; Huang AJ; Firestone GL
Mol Endocrinol; 1997 Mar; 11(3):312-29. PubMed ID: 9058378
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of melanoma inhibitory activity (MIA) expression in melanoma cells leads to molecular and phenotypic changes.
Tatzel J; Poser I; Schroeder J; Bosserhoff AK
Pigment Cell Res; 2005 Apr; 18(2):92-101. PubMed ID: 15760338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
